🔎 Trials Near Me

መነሻ › ሜላኖማ › ዴላዌር

በዴላዌር ለሜላኖማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለሜላኖማ የሚደረጉ 6 ጥናቶች በዴላዌር ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በዴላዌር ውስጥ ያሉ ከተሞች

Official study text (English)

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05136196

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

  • Alfred I duPont Hospital for Children, Wilmington
ተሳታዮችን በመፈለግ ላይደረጃ 2
እስከ እድሜ 25 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT07621614

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

  • Beebe Medical Center, Lewes
  • Beebe South Coastal Health Campus, Millville
  • Helen F Graham Cancer Center, Newark
  • እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 75 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT07068074

Project: Every Child for Younger Patients With Cancer

  • Alfred I duPont Hospital for Children, Wilmington
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እስከ እድሜ 25 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT02402244

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Beebe South Coastal Health Campus, Millville
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Newark
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።